Kopran Ltd
NSE:KOPRAN

Watchlist Manager
Kopran Ltd Logo
Kopran Ltd
NSE:KOPRAN
Watchlist
Price: 129.93 INR 1.48% Market Closed
Market Cap: 6.3B INR

Operating Margin
Kopran Ltd

6.5%
Current
9%
Average
6.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
6.5%
=
Operating Profit
384.1m
/
Revenue
5.9B

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
IN
Kopran Ltd
NSE:KOPRAN
6.2B INR
6%
US
Eli Lilly and Co
NYSE:LLY
999.6B USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
501.2B USD
27%
CH
Roche Holding AG
SIX:ROG
256.7B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
210.6B GBP
24%
CH
Novartis AG
SIX:NOVN
206.2B CHF
33%
US
Merck & Co Inc
NYSE:MRK
250.5B USD
38%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
42%
IE
Endo International PLC
LSE:0Y5F
209B USD
11%
US
Pfizer Inc
NYSE:PFE
142.4B USD
29%
No Stocks Found

Kopran Ltd
Glance View

Market Cap
6.3B INR
Industry
Pharmaceuticals

Kopran Ltd. is a holding company, which engages in the manufacturing of pharmaceuticals and related products. The company is headquartered in Mumbai, Maharashtra. The firm is engaged in the business of manufacturing and supplying international formulations (Finished Dosage Form) and active pharmaceutical ingredients (APIs). Its formulation business unit manufactures oral solid dosages and dry powder formulations for both penicillin and non-penicillin-based drugs. Its APIs business unit offers Sterile Cephalosporins and Carbapenems. The company also offers Macrolide, Antibacterial, Anticonvulsant, and Cardiovascular range of drugs. Its product offering includes antibiotics, cardiovascular, antidiabetic, gastrointestinal, pain management, drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, and anthelmintics. Its antibiotics brands include AMPIK 250 / 500, AMPIK SYRUP, and AMYN - 250 / 500. Its cardiovascular brands include CARDIOTEN - 25 / 50 / 100, CADITONE - 3.125 / 6.25 / 12.5 / 25 and KLODIP - 5 / 10.

KOPRAN Intrinsic Value
128.43 INR
Overvaluation 1%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
6.5%
=
Operating Profit
384.1m
/
Revenue
5.9B
What is the Operating Margin of Kopran Ltd?

Based on Kopran Ltd's most recent financial statements, the company has Operating Margin of 6.5%.

Back to Top